LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced that it has launched the ...

Agreement reached for Gyroscope Therapeutics to be acquired by Novartis for up to $1.5 billion (£1.1 billion1) with an upfront cash payment of $800 million (£604 million) and up to $700 million (£528 ...

New York, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gyroscope Global Market Report 2022" - https://www.reportlinker.com ...

LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye, announced today it has raised USD $148.0 million (£107.8 million ...